×
About 320 results

ALLMedicine™ Ampullary Carcinoma Center

Research & Reviews  115 results

Percutaneous Transhepatic Cholangiography
http://emedicine.medscape.com/article/1828033-overview

Aug 2nd, 2022 - Background Over the past few decades, biliary interventions have evolved a great deal. Opacification of the biliary system was first reported in 1921 with direct puncture of the gallbladder. Subsequent reports described direct percutaneous biliary...

Percutaneous Transhepatic Cholangiography
https://emedicine.medscape.com/article/1828033-overview

Aug 2nd, 2022 - Background Over the past few decades, biliary interventions have evolved a great deal. Opacification of the biliary system was first reported in 1921 with direct puncture of the gallbladder. Subsequent reports described direct percutaneous biliary...

Percutaneous Transhepatic Cholangiography
https://emedicine.medscape.com/article/1828033-print

Aug 2nd, 2022 - Background Over the past few decades, biliary interventions have evolved a great deal. Opacification of the biliary system was first reported in 1921 with direct puncture of the gallbladder. Subsequent reports described direct percutaneous biliary...

Open Versus Laparoscopic Assisted Pancreaticoduodenectomy
https://clinicaltrials.gov/ct2/show/NCT05463328

Jul 19th, 2022 - Pancreaticoduodenectomy is the only option curative intended in the treatment of resectable pancreatic ductal adenocarcinomas, duodenal carcinoma, ampullary carcinoma, lower common bile duct cholangiocarcinoma,. It is still associated with very hi...

A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients
https://clinicaltrials.gov/ct2/show/NCT04492033

Jun 30th, 2022 - Phase 1b Study: Indication of phase 1b study is the advanced or metastatic solid tumors (including, but not limited to, colorectal cancer, gastric cancer, and ovarian cancer). Phase 2 Study: Indication of phase 2 study is unresectable advanced, me...

see more →

Clinicaltrials.gov  11 results

Open Versus Laparoscopic Assisted Pancreaticoduodenectomy
https://clinicaltrials.gov/ct2/show/NCT05463328

Jul 19th, 2022 - Pancreaticoduodenectomy is the only option curative intended in the treatment of resectable pancreatic ductal adenocarcinomas, duodenal carcinoma, ampullary carcinoma, lower common bile duct cholangiocarcinoma,. It is still associated with very hi...

A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients
https://clinicaltrials.gov/ct2/show/NCT04492033

Jun 30th, 2022 - Phase 1b Study: Indication of phase 1b study is the advanced or metastatic solid tumors (including, but not limited to, colorectal cancer, gastric cancer, and ovarian cancer). Phase 2 Study: Indication of phase 2 study is unresectable advanced, me...

The Effect of Overtime Pancreaticoduodenectomy on the Short-term Prognosis of Patients(EOPSPP)
https://clinicaltrials.gov/ct2/show/NCT04881734

May 12th, 2021 - Research Background Due to the large number of operations, surgeons sometimes need to work overtime to perform elective surgery. At this time, surgeons need to perform the operation under fatigue or even sleep deprivation. Fatigue and sleep depriv...

Endobiliary RFA for Unresectable Malignant Biliary Strictures
https://clinicaltrials.gov/ct2/show/NCT01844245

Oct 14th, 2020 - RFA is well established method for treatment of some solid tumors, like liver cancer, lung cancer, etc. Recently, an endoscopically applicable radiofrequency probe, HabibTM EndoHBP catheter, was approved for clinical use. It uses bipolar electrica...

Postoperative Pancreatitis and Its Correlation With Clinically Relevant Pancreatic Fistula in Pancreaticoduodenectomy
https://clinicaltrials.gov/ct2/show/NCT04514198

Aug 18th, 2020 - STUDY PROCEDURE: Demographic, pathological and intraoperative data will be recorded in a prospectively maintained database populated from a combination of electronic patient records, preoperative imaging and anaesthetic charts. Preoperative clinic...

see more →

News  1 results

Adjuvant Therapy for Biliary Tract Cancers Advance
https://www.onclive.com/view/adjuvant-therapy-for-biliary-tract-cancers-advance

Dec 20th, 2020 - Laura W. Goff, MD Associate Professor, Medicine Associate Director, Hematology/ Oncology Fellowship Program Marc Roth, MD Resident Department of Internal Medicine Vanderbilt-Ingram Cancer Center Nashville, Tennessee Biliary trac...

see more →

Patient Education  1 results see all →